Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center

BACKGROUND: A salutary effect of treatments for Gaucher disease (GD) has been a reduction in the incidence of avascular osteonecrosis (AVN). However, there are reports of AVN in patients receiving enzyme replacement therapy (ERT) , and it is not known whether it is related to individual treatments,...

Descripción completa

Detalles Bibliográficos
Autores principales: Basiri, Mohsen, Ghaffari, Mohammad E, Ruan, Jiapeng, Murugesan, Vagishwari, Kleytman, Nathaniel, Belinsky, Glenn, Akhavan, Amir, Lischuk, Andrew, Guo, Lilu, Klinger, Katherine, Mistry, Pramod K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317498/
https://www.ncbi.nlm.nih.gov/pubmed/37249220
http://dx.doi.org/10.7554/eLife.87537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317498/
https://www.ncbi.nlm.nih.gov/pubmed/37249220
http://dx.doi.org/10.7554/eLife.87537

Ejemplares similares